Audited Financial statements & results for the quarter and year ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shree Hari Chemicals Export Limited reported audited standalone revenue of Rs. 18,450.48 Lakhs for FY2026, up 30.7% from Rs. 14,119.58 Lakhs in FY2025. However, standalone net profit declined 17.6% to Rs. 422.22 Lakhs from Rs. 512.40 Lakhs. Consolidated net profit fell 19.2% to Rs. 411.81 Lakhs from Rs. 509.75 Lakhs. The company has two wholly-owned subsidiaries: Shakhambhari Dyechem and Shakhambhari Chemtech. EBITDA margin compressed significantly from 8.13% in FY2025 to approximately 5.31% in FY2026. Borrowings increased substantially with consolidated non-current liabilities rising from Rs. 419.94 Lakhs to Rs. 878.95 Lakhs. The auditor issued an unmodified opinion with no qualifications or emphasis of matter. The company disclosed it qualifies as a Large Corporate under SEBI rules with outstanding qualified borrowings of Rs. 28.38 Crore at year end.
Strong top-line growth of 30.7% was offset by a 17-19% decline in net profit and significant EBITDA margin compression of nearly 3 percentage points. The sharp increase in borrowings and widening gap between revenue growth and profitability raises concerns about cost efficiency and financial health.